欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/3096/004
药品名称
Cresnisol
活性成分
Alanine 21.7 g/l
Arginine 14.7 g/l
Aspartic acid 4.34 g/l
Glutamic acid 7.49 g/l
Glycine 10.4 g/l
Histidine 8.94 g/l
Isoleucine 7.49 g/l
Leucine 10.4 g/l
Lysine 11.8 g/l
Methionine 7.49 g/l
Phenylalanine 10.4 g/l
Proline 8.94 g/l
Serine 5.92 g/l
Threonine 7.49 g/l
Tryptophan 2.5 g/l
Tyrosine 0.39 g/l
Valine 9.6 g/l
剂型
Solution for infusion
上市许可持有人
Baxter A/S Tobaksvejen 2 A 2860 Søborg Denmark
参考成员国 - 产品名称
Denmark (DK)
Cresnisol
互认成员国 - 产品名称
Germany (DE)
Flosol 15 % Infusionslösung
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
France (FR)
许可日期
2021/01/13
最近更新日期
2024/12/12
药物ATC编码
B05BA01 amino acids
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
common_interpack_cresnisol_n10_20210112
Date of last change:2024/09/06
Final Labelling
|
common_interpack_cresnisol_n18_20210112
Date of last change:2024/09/06
Final Labelling
|
common_interpack_cresnisol_n24_20210112
Date of last change:2024/09/06
Final PL
|
common_pl_cresnisol_wolytes_20210112
Date of last change:2024/09/06
Final SPC
|
common_spc_cresnisol_wolytes_20210112
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase